Sangui and SastoMed Complement Licensing Agreement in View of Increasing Sales Success Witten, Germany, August 27, 2012Sangui Biotech International Inc • September 5th, 2012 • Pharmaceutical preparations
Sangui BioTech GmbH and SastoMed GmbH cordially adjusted the existing sales strategy as the introduction of Granulox to professional circles proves to be increasingly successful. In consideration of corresponding contributions the existing licensing contract was partially complemented resulting in the following conditions:
